BioPreventiveMedicine’s DNlite-IVD103 has approved by SFDA
撰文GlobalBio & Investment
日期2023-12-31
BioPreventiveMedicine’s DNlite-IVD103 has approved by SFDA
“An ounce of prevention is worth a pound of cure”. Let’s give a round of applause to
#BioPreventiveMedicine’s DNlite-IVD103! This state-of-the-art test is capable of predicting
#kidney function decline in people with type 2
#diabetes and monitoring the progress of kidney transplant. The Saudi Food and Drug Agency (
#SFDA) has approved this innovative assay and we have heard rumors that distributors are already showing interest.
Stay up-to-date with
#globalbio for the latest news and click here for more insights.
https://lnkd.in/gPGxKsbS
#AKI #KidneyInjury
bio preventive medicine
- © news.gbimonthly.com. All rights reserved. 環球生技版權所有,未經授權請勿轉載。授權合作請洽環球生技編輯部。